KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr3/2022
Data sporządzenia: 2022-04-11
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
Commencing Sales of CompuFlo Epidural / CathCheck Verification System Disposables to a Premier Northeast Hospital in the U.S.
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has commenced sales of its CompuFlo® Epidural and CathCheck™ Verification System disposables to a leading northeast medical center in the U.S. The name of the hospital cannot be disclosed for confidentiality reasons. The Board of Directors of the Company is pleased to announce adoption of our CompuFlo Epidural and CathCheck Verification System by another leading medical center. This approval follows an extensive trial and evaluation, which validates the safety and efficacy of the technology. As a teaching hospital, the Company’s tools provide residents, fellows and seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement. With the addition of this hospital the Company continues to expand the national footprint in the labor and delivery market.
MESSAGE (ENGLISH VERSION)
MILESTONE MEDICAL INC
(pełna nazwa emitenta)
MILESTONE MEDICAL
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
(ulica)(numer)
+11 973 535 2717+11 973 535 2829
(telefon)(fax)
(e-mail)(www)
27-5484393
(NIP)(REGON)
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2022-04-11Keisha HarcumControllerKeisha Harcum